Company Details

Pathway Therapeutics
409 Illinois Street, San Francisco, California, 94158, United States
Overview
Developing selective PI3K inhibitors for cancer and inflammatory diseases.
Total Raised
$12 M
Rounds
2
Links
Verticals
Biotechnology
Medical Device
Therapeutics
Investment History
Equity
May 2011
$8M
Series A
Aug 2010
$5M